Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Acta Neuropathologica Communications|February 18, 2014
Autophagy-lysosome pathway associated neuropathology and axonal degeneration in the brains of alpha-galactosidase A-deficient miceMichael P Nelson, Tonia E Tse, Darrel B O'Quinn, et al.The Journal of Biological Chemistry|February 4, 2010
Lysosome dysfunction triggers Atg7-dependent neural apoptosisKen C Walls, Arindam P Ghosh, Aimee V Franklin, et al.Journal of Neurochemistry|June 11, 2010
Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunctionVioletta N Pivtoraiko, Adam J Harrington, Burton J Mader, et al.Plos One|April 4, 2014
ATP6V0C knockdown in neuroblastoma cells alters autophagy-lysosome pathway function and metabolism of proteins that accumulate in neurodegenerative diseaseLeandra R Mangieri, Burton J Mader, Cailin E Thomas, et al.Neurobiology of Disease|December 3, 2017
The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synucleinMichael P Nelson, Michel Boutin, Tonia E Tse, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 9, 2022
Brief Report: Intracellular Cystatin B Levels Are Altered in HIV-Infected Participants With Respect to Neurocognitive Status and Antiretroviral TherapySkye Opsteen, David Moylan, Babafemi O Taiwo, et al.Molecular Cancer Therapeutics|February 28, 2013
A novel sulindac derivative inhibits lung adenocarcinoma cell growth through suppression of Akt/mTOR signaling and induction of autophagyEvrim Gurpinar, William E Grizzle, John J Shacka, et al.Molecular Brain|July 21, 2017
O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson's diseaseWillayat Y Wani, Xiaosen Ouyang, Gloria A Benavides, et al.Journal of Neuro-Oncology|March 26, 2013
Mutant tristetraprolin: a potent inhibitor of malignant glioma cell growthEsther A Suswam, John J Shacka, Kiera Walker, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 7, 2013
MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegenerationAshley S Harms, Shuwen Cao, Amber L Rowse, et al.Pageof 4